{"id":77633,"date":"2011-11-29T23:55:00","date_gmt":"2011-11-29T23:55:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/"},"modified":"2011-11-29T23:55:00","modified_gmt":"2011-11-29T23:55:00","slug":"un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/","title":{"rendered":"Un estudio analiza la compatibilidad f\u00edsico-qu\u00edmica de varios medicamentos en pacientes cr\u00edticos"},"content":{"rendered":"<p>\u00a0<\/p>\n<p>\u00a0<span>Barcelona, noviembre de 2011.-<\/span><span>\u00a0<\/span><strong>Un estudio realizado por el Servicio de Farmacia del Hospital Cl\u00ednic y becado por el Colegio de Farmac\u00e9uticos de Barcelona<\/strong><span>\u00a0<\/span><span>ha permitido analizar la compatibilidad f\u00edsico-qu\u00edmica de 63 mezclas binarias de f\u00e1rmacos utilizados habitualmente en perfusi\u00f3n continua en pacientes cr\u00edticos en las Unidades de Cuidados Intensivos.<\/span><\/p>\n<p>El paciente cr\u00edtico requiere a menudo tratamiento con distintos f\u00e1rmacos intravenosos. El hecho de que muchos de estos f\u00e1rmacos se administren en continua perfusi\u00f3n, unido al inconveniente de que los accesos venosos en este enfermo son limitados, hacen que el personal de enfermer\u00eda se vea obligado a administrar simult\u00e1neamente varios f\u00e1rmacos por una misma v\u00eda. Por eso, disponer de informaci\u00f3n contrastada sobre la compatibilidad de estos medicamentos es importante para evitar posibles errores y asegurar una terapia \u00f3ptima. En este caso, el estudio consisti\u00f3 en el an\u00e1lisis de distintas mezclas binarias, en distintos diluyentes y condiciones de exposici\u00f3n a la luz, hasta un total de 130 combinaciones. Los resultados obtenidos han permitido completar la informaci\u00f3n contenida en una tabla de estabilidades, previamente elaborada con datos extra\u00eddos de la literatura cient\u00edfica, en la que enfermer\u00eda puede consultar con facilidad la compatibilidad de las mezclas.<\/p>\n<p>Los autores del estudio conf\u00edan en que la informaci\u00f3n derivada del trabajo permita ampliar el conocimiento sobre compatibilidad f\u00edsico-qu\u00edmica de mezclas endovenosas de uso frecuente en las Unidades de Cuidados Intensivos y contribuya a mejorar la administraci\u00f3n segura de medicamentos en el paciente cr\u00edtico.<\/p>\n<p>Autores del estudio \u201cCompatibilidad f\u00edsico-qu\u00edmica de f\u00e1rmacos administrados en perfusi\u00f3n continua en las Unidades de Cuidados Intensivos\u201d<br \/>Carmen L\u00f3pez Cabezas, Dolores Soy Muner, Laura Guerrero Molina, Gloria Molas Ferrer, Helena Anglada Mart\u00ednez, Josep Ribas Sala. Servicio de Farmacia Hospital Cl\u00ednic de Barcelona.<\/p>\n<p>Para m\u00e1s informaci\u00f3n:<\/p>\n<p>Departamento de Comunicaci\u00f3n del Colegio de Farmac\u00e9uticos de Barcelona<br \/>Tel\u00e9fono: 93 244 07 28 \/ 18 \u2013 E-mail:\u00a0<a href=\"mailto:premsa@cofb.net\">premsa@cofb.net<\/a><\/p>\n<p>\u00a0\u00a0Barcelona, noviembre de 2011.- Un estudio realizado por el Servicio de Farmacia del Hospital Cl\u00ednic y becado por el Colegio de Farmac\u00e9uticos de Barcelona ha permitido analizar la compatibilidad f\u00edsico-qu\u00edmica de 63 mezclas binarias de f\u00e1rmacos utilizados habitualmente en perfusi\u00f3n continua en pacientes cr\u00edticos en las Unidades de Cuidados Intensivos. El paciente cr\u00edtico requiere a menudo tratamiento con diferentes f\u00e1rmacos intravenosos. El hecho de que muchos de estos f\u00e1rmacos se administren en continua perfusi\u00f3n, unido al inconveniente de que los accesos venosos en este enfermo son limitados, hacen que el personal de enfermer\u00eda se vea obligado a administrar simult\u00e1neamente varios f\u00e1rmacos por una misma v\u00eda. Por eso, disponer de informaci\u00f3n contrastada sobre la compatibilidad de estos medicamentos es importante para evitar posibles errores y asegurar una terapia \u00f3ptima. En este caso, el estudio consisti\u00f3 en el an\u00e1lisis de distintas mezclas binarias, en distintos diluyentes y condiciones de exposici\u00f3n a la luz, hasta un total de 130 combinaciones. Los resultados obtenidos han permitido completar la informaci\u00f3n contenida en una tabla de estabilidades, previamente elaborada con datos extra\u00eddos de la literatura cient\u00edfica, en la que enfermer\u00eda puede consultar con facilidad la compatibilidad de las mezclas. Los autores del estudio conf\u00edan en que la informaci\u00f3n derivada del trabajo permita ampliar el conocimiento sobre compatibilidad f\u00edsico-qu\u00edmica de mezclas endovenosas de uso frecuente en las Unidades de Cuidados Intensivos y contribuya a mejorar la administraci\u00f3n segura de medicamentos en el paciente cr\u00edtico. Autores del estudio \u201cCompatibilidad f\u00edsico-qu\u00edmica de f\u00e1rmacos administrados en perfusi\u00f3n continua en las Unidades de Cuidados Intensivos\u201d Carmen L\u00f3pez Cabezas, Dolores Soy Muner, Laura Guerrero Molina, Gloria Molas Ferrer, Helena Anglada Mart\u00ednez, Josep Ribas Sala. Servicio de Farmacia Hospital Cl\u00ednic de Barcelona.Para m\u00e1s informaci\u00f3n:Departamento de Comunicaci\u00f3n del Colegio de Farmac\u00e9uticos de BarcelonaTel\u00e9fono.: 93 244 07 28 \/ 18 \u2013 E-mail: premsa@cofb.net COFB.ORG<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00a0 \u00a0Barcelona, noviembre de 2011.- Un estudio realizado por el Servicio de Farmacia del Hospital Cl\u00ednic y becado por el Colegio de Farmac\u00e9uticos de Barcelona ha permitido analizar la compatibilidad f\u00edsico-qu\u00edmica de 63 mezclas binarias de f\u00e1rmacos utilizados habitualmente en perfusi\u00f3n continua en pacientes cr\u00edticos en las Unidades de Cuidados Intensivos. El [\u2026]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77633","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 \u00a0Barcelona, novembre de 2011.-\u00a0Un estudi dut a terme pel Servei de Farm\u00e0cia de l\u2019Hospital Cl\u00ednic i becat pel Col\u2022legi de Farmac\u00e8utics de Barcelona\u00a0ha perm\u00e8s analitzar la compatibilitat f\u00edsico-qu\u00edmica de 63 barreges bin\u00e0ries de f\u00e0rmacs utilitzats habitualment en perfusi\u00f3 cont\u00ednua en pacients cr\u00edtics a les Unitats de Cures Intensives. El [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2011-11-29T23:55:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics\",\"datePublished\":\"2011-11-29T23:55:00+00:00\",\"dateModified\":\"2011-11-29T23:55:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/\"},\"wordCount\":693,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"articleSection\":[\"Notes de premsa\",\"Sense categoria\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/\",\"name\":\"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"datePublished\":\"2011-11-29T23:55:00+00:00\",\"dateModified\":\"2011-11-29T23:55:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/","og_locale":"es_ES","og_type":"article","og_title":"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 \u00a0Barcelona, novembre de 2011.-\u00a0Un estudi dut a terme pel Servei de Farm\u00e0cia de l\u2019Hospital Cl\u00ednic i becat pel Col\u2022legi de Farmac\u00e8utics de Barcelona\u00a0ha perm\u00e8s analitzar la compatibilitat f\u00edsico-qu\u00edmica de 63 barreges bin\u00e0ries de f\u00e0rmacs utilitzats habitualment en perfusi\u00f3 cont\u00ednua en pacients cr\u00edtics a les Unitats de Cures Intensives. El [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2011-11-29T23:55:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics","datePublished":"2011-11-29T23:55:00+00:00","dateModified":"2011-11-29T23:55:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/"},"wordCount":693,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"articleSection":["Notes de premsa","Sense categoria"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/","url":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/","name":"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"datePublished":"2011-11-29T23:55:00+00:00","dateModified":"2011-11-29T23:55:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2011\/11\/29\/un-estudi-analitza-la-compatibilitat-fisico-quimica-de-diversos-medicaments-en-pacients-critics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Un estudi analitza la compatibilitat f\u00edsico-qu\u00edmica de diversos medicaments en pacients cr\u00edtics"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 \u00a0Barcelona, novembre de 2011.-\u00a0Un estudi dut a terme pel Servei de Farm\u00e0cia de l\u2019Hospital Cl\u00ednic i becat pel Col\u2022legi de Farmac\u00e8utics de Barcelona\u00a0ha perm\u00e8s analitzar la compatibilitat f\u00edsico-qu\u00edmica de 63 barreges bin\u00e0ries de f\u00e0rmacs utilitzats habitualment en perfusi\u00f3 cont\u00ednua en pacients cr\u00edtics a les Unitats de Cures Intensives. El [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/77633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=77633"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/77633\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=77633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=77633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=77633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}